Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...
Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...
News-Medical.Net on MSN
Repurposed Alzheimer’s medication offers low-cost hope for sickle cell anemia
Sickle cell anemia is the world's most common genetic disorder. It causes the red blood pigment hemoglobin to crystallize, ...
GLP-1 receptor agonist use appeared linked to significantly reduced all-cause mortality among people with sickle cell disease ...
A year ago, NBC News joined Wedam Minyila as he began undergoing a groundbreaking treatment for sickle cell disease. The ...
The firm expects its $1.25 billion cash runway to cover operating and capital expenses through 2029, including development plans for key assets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback